Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 1
2(50.0%)
4Total
N/A(2)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07416396Phase 1Active Not Recruiting

Morning-Evening Specific Longevity Food Supplement

Role: collaborator

NCT07404449Phase 1Active Not Recruiting

Sex-Speciffic Longevity Food Supplements

Role: collaborator

NCT06736366Not ApplicableCompleted

Study With Two Coenzyme Q10 Products

Role: collaborator

NCT05333315Not ApplicableCompleted

Clinical Trials of Five Different Food Supplements With Restriction Diet in Adults

Role: collaborator

All 4 trials loaded